ID: ALA1923416

Max Phase: Preclinical

Molecular Formula: C18H20FN3O2

Molecular Weight: 329.37

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Fc1ccc(CN2CCN(c3ccc4c(c3)OCCO4)CC2)cn1

Standard InChI:  InChI=1S/C18H20FN3O2/c19-18-4-1-14(12-20-18)13-21-5-7-22(8-6-21)15-2-3-16-17(11-15)24-10-9-23-16/h1-4,11-12H,5-10,13H2

Standard InChI Key:  NAIGOHVHPOGNLZ-UHFFFAOYSA-N

Associated Targets(Human)

Dopamine D2 receptor 23596 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Dopamine D3 receptor 14368 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Dopamine D4 receptor 7907 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Dopamine D1 receptor 376 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Serotonin 2a (5-HT2a) receptor 150 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 329.37Molecular Weight (Monoisotopic): 329.1540AlogP: 2.31#Rotatable Bonds: 3
Polar Surface Area: 37.83Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 6.45CX LogP: 2.48CX LogD: 2.44
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.81Np Likeness Score: -1.58

References

1. Kügler F, Sihver W, Ermert J, Hübner H, Gmeiner P, Prante O, Coenen HH..  (2011)  Evaluation of 18F-labeled benzodioxine piperazine-based dopamine D4 receptor ligands: lipophilicity as a determinate of nonspecific binding.,  54  (24): [PMID:22039961] [10.1021/jm200762g]

Source